Ovid therapeutics inc.

Major-Pharmaceuticals

OVID


1460 Broadway
New York , NY 10036

Executive/
Director

Price

  • Last Close
  • $ 0.96
    $ -0 -0.21 %
    Jan 3, 2025
  • 52-Week High/Low
  • $4.04 - $0.7
  • YTD
  • 1.4%

  • Trading Volume
  • 1,513
  • Market Cap Full
  • $ 67.9M
  • Shares Outstanding
  • 70.7M
    Oct 31, 2023
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Q1 - - -28.4% -26.9% -5% 74% -2.2% 38.7% -5% 1.4%
Q2 - -14.4% 26.6% 3.4% 4% -2.7% -31.5% 27.1% -76.6% -
Q3 - -18.3% -30.3% 55.3% 8% -14.1% -14.4% 17.1% 14.4% -
Q4 - 14.6% -57.7% 35.1% -59.8% -4.5% 1.1% -9.6% -20.4% -
J F M A M J J A S O N D
2025 1.4% - - - - - - - - - - -
2024 20.2% -12.1% -10% 5.6% -5.1% -76.4% 43.7% 14.4% - - - -
    2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
    0%0%0%-75%80%-47%39%-42%73%-71%1%

Earnings

2016 2017 2018 2019 2020 2021 2022 2023
Q1 - 3.48 -0.54 -0.46 -0.37 2.53 - -0.19
Q2 - 0.57 -0.53 -0.34 -0.41 -0.23 - -0.18
Q3 - 0.38 -0.53 -0.43 -0.28 - - -0.16
Q4 - 0.45 -0.51 -0.31 -0.33 1.76 -0.16 -
A 0 4.9 -2.1 -1.5 -1.4 1.8 -0.8 -0.53

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022 2023
Mar - 38.6 54.7 65.8 70.4 70.5
Jun 24.6 38.7 54.8 67.8 70.4 70.5
Sep 24.6 38.7 57.1 67.9 70.4 70.6
Dec 24.7 47.8 63.4 68.1 70.5 70.7

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover 0.2 52 13 - -
Total Asset Turnover - 1.1 0.2 - -
Leverage
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Interest Coverage 28 124 - 61 53
Equity multiplier 0.1 - - - 0.1